News

Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense (DoD) to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat.

Under the three-year grant, investigators will test the safety and effectiveness of two newly developed antibodies to treat proliferative vitreoretinopathy, or PVR. Currently not treatable or preventable,...

Dr. Costantino Iadecola, director and chair of the Feil Family Brain and Mind Research Institute and the Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, has been awarded the 2021 Basic Research Prize from the American Heart Association (AHA).

The AHA Basic Research Prize is given annually to an individual in recognition...

The degree to which the brain’s wiring aligns with its patterns of activity can vary with sex and age, and may be genetic, suggests a study published by Weill Cornell Medicine investigators. The study finds that this alignment may also have implications on cognition.

The results published July 12 in Nature Communications help shed light on one of the biggest mysteries in biology—how the brain works, according to senior...

Women become more susceptible to hypertension as they approach menopause, and now a preclinical study led by researchers at Weill Cornell Medicine’s Feil Family Brain and Mind Research Institute suggests that this “perimenopausal” hypertension may be driven by declines in estrogen signaling in a brain region called the hypothalamus—and may be preventable with estrogen-like treatments.

In the...